Professional Documents
Culture Documents
N00936334
HUN 3230
Fatty acids, the major form of dietary fat, are classified into several different groups: total
fat, n-3 and n-6 polyunsaturated fatty acids (PUFAs), monounsaturated fatty acids (MUFAs),
saturated fatty acids (SFAs) and trans-fatty acids (TFAs). Each has its own biological effects and
structural differences. SFAs have no double bonds, while MUFAs have one double bond and
PUFAs have more than one double bond (as well as the variety of cis or trans configurations).
Furthermore, n-3 PUFAs have a double bond occurring at the third carbon of the fatty acid chain
from the methyl end, while n-6 PUFAs have a double bond occurring at the sixth carbon. Each
fatty acid has its own biological effect. Due to the extensive nature of fats, the Academy of
Nutrition and Dietetics (AND) has created a position statement in regards to dietary fatty acids
It is the position of the Academy of Nutrition and Dietetics that dietary fat for the
healthy adult population should provide 20% to 35% of energy, with an increased
consumption of n-3 polyunsaturated fatty acids and limited intake of saturated and trans
fats. The Academy recommends a food-based approach through a diet that includes
regular consumption of fatty fish, nuts and seeds, lean meats and poultry, low-fat dairy
fat is of tantamount importance. PUFAs, which are liquid at room temperature, are most
commonly known for the n-3 and n-6 versions. Both are essential fatty acids, for humans are
unable to synthesize them. Each has its own benefits. Alpha-linolenic acid (ALA) is the most
abundant n-3 PUFA, many of which are strongly correlated with heart health. Specific n-3
PUFAs associated with cardiovascular benefits are ALA, EPA, and DHA. Diets rich in ALA
have been found to lower lipid levels, reduce vascular inflammation, and reduce blood pressure,
while there have been positive associations between EPA and DHA (commonly found in fatty
fish) and decreased risk of cognitive decline.1 More general studies have found a link between
inadequate intake of n-3 has been linked with depression and an increased risk of sudden cardiac
death.1 It is recommended that n-3 intake should be 0.6% to 1.2% of daily caloric intake. In
reverence to n-6 PUFAs, LA is the most highly consumed PUFA in the Western diet, as well as
the metabolic precursor of arachidonic acid (ARA). ARA can contribute to overproduction of
eicosanoids, which have been linked with negative effects such as inflammation,
vasoconstriction, and platelet aggregation. Due to this, n-6 PUFA intake should be limited to 5%
MUFA supplementation is not common practice since it is abundant in various foods and
oils. MUFA intake has been linked to alteration in markers of health and disease, such as
reducing LDL cholesterol, triglycerides, total cholesterol to HDL ratio, and increasing HDL
cholesterol.1 Although there have been positive correlations, there have also been negative ones.
Over a 30 year assessment, MUFA levels were positively associated with coronary death.1
Current recommendations for MUFA intake are consuming no more than 12% of energy. SFA
intake should not exceed 7% of energy intake; according to the AHAs Diet and Lifestyle
Recommendations (2006).1 This limited intake of SFAs is recommended due to its negative
effects including increased LDL cholesterol levels. An exception for SFA supplements are
medium chain fatty acids (MCTs). MCT supplements, derived from coconut oil, are used for
medical nutrition therapy (MNT) in patients who lack the ability to properly metabolize long-
chain fatty acids (LCFAs).1 Lastly, trans-fatty acid intake should be as low as possible. It has
been concluded that absolutely any TFA intake increases risk of developing CHD, metabolic
syndrome and diabetes.1 Although TFA intake has been declining over the years, it is important
been conducted since the publication of the Academys statement that further supports its
conclusions. Although there have been multiple studies published in relation to the beneficial
health effects of fatty acids, several have specifically focused on the negative health effects of
certain types of fatty acids. A study conducted by Cen et al has results suggestive of long-chain
free fatty acids (FFAs) having an enhancing effect on insulin secretion (even at low glucose
concentrations), with MUFAs (palmitoleate or oleate) being more potent than SFAs (palmitate or
stearate). These results were primarily due to mitochondrial respiration and increased glycolytic
flux. There are implications that there are stimulatory effects of fatty acids on insulin secretion at
fasting glucose concentrations. This may contribute to hyperinsulinemia (often linked with
insulin resistance, and eventually the diagnosis of type 2 diabetes) in subjects with elevated
levels of FFAs.2
One 20-week animal study conducted research on the effects of trans-fatty acids on
obesity, insulin resistance (IR) and hepatic steatosis. Six male mice were fed four different diets
for 20 weeks: normal diet (ND, 25% kcal from fat), high fat diet (HFD, 50% kcal from fat), low
trans-fatty acids diet (LTD, 25% kcal from fat) and high trans-fatty acid diet (HTD, 50% kcal
from fat). Results concluded that the HTD diet produced the highest body weights and further
impaired glucose tolerance (with HFD as second). The HTD group also showed more severe
liver steatosis in comparison to the other groups. It was concluded that ...consumption of a diet
high in trans-fatty acids induces higher rates of obesity, IR and hepatic steatosis3 The
importance of this study is great, as overconsumption of fatty acids leads to deposition directly to
the liver. This can eventually lead to steatohepatitis, hepatic fibrosis, and further liver damage.
This studys results prove that trans-fatty acids are a risk factor for obesity, IR, and metabolic
syndrome. Specifically, mice on the HTD diet in comparison to the HFD diet suffered glucose
intolerance more severely. Animal studies are not necessarily reliable for drawing concrete
conclusions for human subjects, yet this study gives great insight to the consequences of
consumption of trans-fatty acids such as the promotion of lipid accumulation in the liver and
As discussed in the Academy of Nutrition and Dietetics position paper, each fatty acid
has its own beneficial and/or negative biological effect on the body. Due to this, each fatty acid
has an intake recommendation from the Academy. As supported through Xiaona et als study,
trans-fatty acid intake should be as minimal as possible, as the effects are detrimental. MUFAs,
which tend to be higher in the Mediterranean diet due to the abundance in olive oil, have positive
effects on over secretion of insulin. Although optimal intake of MUFA in still to be determined,
the key is to make MUFA intake balanced. Replacement of SFAs with n-3 and n-6 PUFAs have
been encouraged for the inverse association between PUFA levels and sudden cardiac death. The
Academy's position statement has certainly been supported throughout a range of research
studies, although clarification must be made that findings from animal studies cannot always be
applicable to human subjects. Therefore, it is the job of registered dietitian nutritionists (RDNs)
to help the general public understand the impacts of fatty acids as a whole. Effects of fatty acids
need to be understood in order to eat a healthy balance of them. With their knowledge, RDNs are
experts in the area of making realistic goals in regards to fat intake - nutrition education
(specifically in regards to fat) through RDNs can influence lifelong health and longevity.
References
1. Vannice G, Rasmussen H. From the Academy: Position of the Academy of Nutrition and
Dietetics: Dietary Fatty Acids for Healthy Adults. Journal Of The Academy Of Nutrition
2. Jing C, Sargsyan E, Bergsten P. Fatty acids stimulate insulin secretion from human
Resistance and Hepatic Steatosis in C57BL/6 Mice, Possibly by Suppressing the IRS1